We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
-1.9%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$169M
AUM Growth
-$15.1M
Cap. Flow
-$22.7M
Cap. Flow %
-13.45%
Top 10 Hldgs %
33.65%
Holding
197
New
30
Increased
43
Reduced
28
Closed
35

Top Buys

Rank Stock Value
1
ASPN icon
Aspen Aerogels
ASPN
+$3.04M
2
VCNX
Vaccinex, Inc. Common Stock
VCNX
+$2.57M
3
ALIM
Alimera Sciences
ALIM
+$1.96M
4
OUST icon
Ouster
OUST
+$1.74M
5
SILC icon
Silicom
SILC
+$1.63M

Top Sells

Rank Stock Value
1
MCHP icon
Microchip Technology
MCHP
+$5.37M
2
ANIP icon
ANI Pharmaceuticals
ANIP
+$4.71M
3
AVNW icon
Aviat Networks
AVNW
+$1.76M
4
ANVS icon
Annovis Bio
ANVS
+$1.14M
5
CMBM
Cambium Networks
CMBM
+$1.12M

Sector Composition

Rank Sector Weight
1 Healthcare 15.95%
2 Technology 14.24%
3 Financials 7.09%
4 Industrials 3.96%
5 Consumer Staples 1.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACAD icon
101
PUT
Acadia Pharmaceuticals
ACAD
$4.39B
$44.4K 0.03%
+29,600
New +$804K
ILCV icon
102
PUT
iShares Morningstar Value ETF
ILCV
$1.34B
$41.4K 0.02%
78,900
-12,900
-14% -$867K
MRNS
103
CALL
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$40.9K 0.02%
49,500
+5,300
+12% +$44.1K
OEF icon
104
PUT
iShares S&P 100 ETF
OEF
$20.1B
$37K 0.02%
+211,300
New +$44M
MDXH icon
105
MDxHealth
MDXH
$23.4M
$33.7K 0.02%
11,872
+1,472
+14% +$4.9K
TPST icon
106
Tempest Therapeutics
TPST
$14M
$31.8K 0.02%
7,812
– –
ARGX icon
107
CALL
argenx
ARGX
$52B
$29.4K 0.02%
+11,400
New +$5.58M
MIRO
108
DELISTED
Miromatrix Medical Inc. Common Stock
MIRO
$28.4K 0.02%
23,509
+1,709
+8% +$2.49K
LUV icon
109
PUT
Southwest Airlines
LUV
$23B
$25.8K 0.02%
41,000
+17,600
+75% +$574K
XNTK icon
110
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.11B
$23.1K 0.01%
15,400
-20,000
-56% -$2.83M
AMLX icon
111
CALL
Amylyx Pharmaceuticals
AMLX
$2.24B
$23K 0.01%
+22,300
New +$472K
XNTK icon
112
CALL
State Street SPDR NYSE Technology ETF
XNTK
$2.11B
$22.8K 0.01%
+30,800
New +$4.36M
ELUT icon
113
Elutia
ELUT
$38.3M
$22.1K 0.01%
+15,428
New +$27K
SVREW
114
SaverOne 2014 Ltd Warrant
SVREW
$48.9K
$21.2K 0.01%
141,364
– –
AZN icon
115
PUT
AstraZeneca
AZN
$245B
$21K 0.01%
7,700
-60,900
-89% -$8.32M
SNCR
116
DELISTED
Synchronoss Technologies
SNCR
$20.2K 0.01%
2,338
+338
+17% +$3.01K
DFSCW
117
DEFSEC Technologies Warrant
DFSCW
$16.2K 0.01%
147,353
– –
ACONW icon
118
Aclarion Warrant
ACONW
$65.6K
$15.8K 0.01%
178,416
– –
BCS icon
119
PUT
Barclays
BCS
$93.8B
$14.1K 0.01%
52,400
+1,100
+2% +$8.54K
GES
120
PUT
DELISTED
Guess Inc
GES
$13.2K 0.01%
18,200
+6,400
+54% +$135K
ACAD icon
121
CALL
Acadia Pharmaceuticals
ACAD
$4.39B
$10.4K 0.01%
+29,600
New +$804K
XLV icon
122
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$41.8B
$9.55K 0.01%
+15,400
New +$2.04M
AMLX icon
123
PUT
Amylyx Pharmaceuticals
AMLX
$2.24B
$9.48K 0.01%
+22,300
New +$472K
CNK icon
124
PUT
Cinemark Holdings
CNK
$4.39B
$5.89K ﹤0.01%
117,800
-106,400
-47% -$1.78M
GEO icon
125
PUT
The GEO Group
GEO
$4.19B
$5.79K ﹤0.01%
115,400
-9,100
-7% -$66.5K
3 4
5
6 7

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
LGM
Lykos Global Management Stamford, Connecticut $30.4M AUM
SCA
SMH Capital Advisors Fort Worth, Texas $32.9M AUM 1.53% 1-Year Est. Return

Worth Venture Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Worth Venture Partners held 197 positions worth $169M, down 8.2% from $184M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Worth Venture Partners withdrew a net $22.7M in Q3 2023, closing 35 positions and reducing 28 holdings. Its most notable exit was ANI Pharmaceuticals, an estimated $4.71M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Technology and Financials.

Against the trend, Worth Venture Partners opened a new position in Aspen Aerogels worth $3.68M.

  • Worth Venture Partners's largest Q3 2023 buy was Aspen Aerogels: 428,367 shares worth $3.68M.
  • Worth Venture Partners added most to Vaccinex, Inc. Common Stock in Q3 2023, an estimated $2.57M increase.
  • Worth Venture Partners's biggest Q3 2023 reduction was Microchip Technology, cutting an estimated $5.37M.
  • Worth Venture Partners fully exited ANI Pharmaceuticals in Q3 2023, selling an estimated $4.71M.
  • Worth Venture Partners's ten largest holdings make up 34% of its $169M portfolio in Q3 2023.
  • Worth Venture Partners opened 30 new positions and closed 35 in Q3 2023.
  • Worth Venture Partners's portfolio value fell 8.2% quarter-over-quarter to $169M.

Based on Worth Venture Partners's 13F filing for Q3 2023, filed 15 Nov 2023.